Effect of Elimination of Acid Reflux on Epithelial Cell Proliferative Activity of Barrett Esophagus

References

• Paull A, Trier JS, Dalton MD, Camp RC, Loeb P, Goyal RK. The histologic spectrum of Barrett’s esophagus. N Engl J Med 1976;295:476–80.
   PubMed Web of Science ®Google Scholar
• Cameron AJ, Ott BJ, Payne WS. The incidence of adenocarcinoma in columnar-lined (Barrett’s) esophagus. N Engl J Med 1985;313:857–9.
   Google Scholar
• Dent J, Bremner CG, Collen MJ, Haggitt RC, Spechler SJ. Working party report to the World Congress of Gastroenterology, Sydney 1990. Barrett’s oesophagus. J Gastroenterol Hepatol 1991;6: 1–22.
   Google Scholar
• Peters FTM, Kleibeuker JH. Barrett’s oesophagus and carcinoma: recent insights in development and possible prevention. Scand J Gastroenterol 1993;28 Suppl 200:59–64.
   Google Scholar
• Wright TA, Kingsnorth AN. Barrett’s oesophagus and markers of malignant potential. Eur J Gastroenterol Hepatol 1994;6:656–62.
   Google Scholar
• Weinstein WM, Ippoliti AF. The diagnosis of Barrett’s esophagus: goblets, goblets, goblets. Gastrointest Endosc 1996; 44:91–5.
   PubMedGoogle Scholar
• Hamilton SR, Smith RRL. The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett’s esophagus. Am J Clin Pathol 1987;87:301–12.
   PubMed Web of Science ®Google Scholar
• Riddell RH, Goldman H, Ransohoff DF, Appelman HD, Fenoglio CM, Haggitt RC, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical application. Hum Pathol 1983;14:931–68.
   PubMed Web of Science ®Google Scholar
• Reid BJ, Haggitt RC, Rubin CE, Roth G, Surawicz CM, Van Belle G, et al. Observer variation in the diagnosis of dysplasia in Barrett’s esophagus. Hum Pathol 1988;19:166–78.
   Google Scholar
• Miros M, Kerlin P, Walker N. Only patients with dysplasia progress to adenocarcinoma in Barrett’s oesophagus. Gut 1991; 32:1441–6.
   Google Scholar
• Peters FTM, Ganesh S, Kuipers EJ, Jager de-Krikken A, Karrenbeld A, Harms G, et al. Epithelial cell proliferative activity of Barrett’s esophagus: methodology and correlation with traditional cancer risk markers. Dig Dis Sci 1998;43: 1501–6.
   Google Scholar
• Preston-Martin S, Pike MC, Ross RK, Jones PA, Henderson BE. Increased cell division as a cause of human cancer. Cancer Res 1990;50:7415–21.
   PubMed Web of Science ®Google Scholar
• Welberg JWM, de Vries EGE, Hardonk MJ, Mulder NH, Harms G, Grond J, et al. Proliferation rate of colonic mucosa in normal subjects and patients with colonic neoplasms: a refined immunohistochemical method. J Clin Pathol 1990;43:453–6.
   PubMed Web of Science ®Google Scholar
• Ponz de Leon M, Roncucci L, Di Donato P, Tassi L, Smerieri O, Amorico MG, et al. Pattern of epithelial cell proliferation in colorectal mucosa of normal subjects and of patients with adenomatous polyps or cancer of the large bowel. Cancer Res 1988;48:4121–6.
   PubMed Web of Science ®Google Scholar
• Bechi P, Balzi M, Becciolini A, Maugeri A, Raggi CC, Amorosi A, et al. Helicobacter pylori and cell proliferation of the gastric mucosa: possible implications for gastric carcinogenesis. Am J Gastroenterol 1996;91:271–6.
   PubMed Web of Science ®Google Scholar
• Patchett SE, Katelaris PH, Zhang ZW, Alstead EM, Domizio P, Farthing MJG. Ornithine decarboxylase activity is a marker of premalignancy in longstanding Helicobacter pylori infection. Gut 1996;39:807–10.
   PubMedGoogle Scholar
• Peters FTM, Ganesh S, Kuipers EJ, Sluiter WJ, Klinkenberg- Knol EC, Lamers CBHW, et al. Endoscopic regression of Barrett’s oesophagus during omeprazole therapy; a randomized double blind study. Gut 1999;45:489–94.
   Google Scholar
• Lipkin M, Newmark H. Effect of added dietary calcium on colonic epithelial-cell proliferation in subjects at high risk for familial colonic cancer. N Engl J Med 1985;313:1381–4.
   PubMed Web of Science ®Google Scholar
• Wargovich MJ, Isbell G, Shabot M, Winn R, Lanza F, Hochman L, et al. Calcium supplementation decreases rectal epithelial cell proliferation in subjects with sporadic adenoma. Gastroenterology 1992;103:92–7.
   PubMed Web of Science ®Google Scholar
• Cats A, Kleibeuker JH, van der Meer R, Kuipers F, Sluiter WJ, Hardonk MJ, et al. Randomized, double-blinded, placebocontrolled intervention study with supplemental calcium in families with hereditary nonpolyposis colorectal cancer. J Natl Cancer Inst 1995;87:598–603.
   Google Scholar
• Cahill RJ, Xia H, Kilgallen C, Beattie S, Hamilton H, O’Morain C. Effect of eradication of Helicobacter pylori infection on gastric epithelial cell proliferation. Dig Dis Sci 1995;40:1627–31.
   Google Scholar
• Lynch DAF, Mapstone NP, Clarke AMT, Sobala GM, Jackson P, Morrison L, et al. Cell proliferation in Helicobacter pylori associated gastritis and the effect of therapy. Gut 1995;36:346–50.
   PubMed Web of Science ®Google Scholar
• Harms G, van Goor H, Koudstaal J, de Ley L, Hardonk MJ. Immunohistochemical demonstration of DNA-incorporated 5- bromodeoxyuridine in frozen and plastic embedded sections. Histochemistry 1986;85:139–43.
   PubMedGoogle Scholar
• Paganelli GM, Biasco G, Santucci R, Brandi G, Lalli AA, Miglioli M, et al. Rectal cell proliferation and colorectal cancer risk in patients with nonfamilial adenomatous polyps of the large bowel. Cancer 1991;68:2451–4.
   PubMedGoogle Scholar
• Roncucci L, Scalmati A, Ponz de Leon M. Pattern of cell kinetics in colorectal mucosa of patients with different types of adenomatous polyps of the large bowel. Cancer 1991;68:873–8.
   Google Scholar
• Risio M, Lipkin M, Candelaresi GL, Bertone A, Coverlizza S, Rossini FP. Correlations between rectal mucosa cell proliferation and the clinical and pathological features of nonfamilial neoplasia of the large intestine. Cancer Res 1991;51:1917–21.
   PubMed Web of Science ®Google Scholar
• Scalmati A, Roncucci L, Ghidini G, Biasco G, Ponz de Leon M. Epithelial cell kinetics in the remaining colorectal mucosa after surgery for cancer of the large bowel. Cancer Res 1990;50: 7937–41.
   Google Scholar
• Offerhaus GJA, van de Stadt J, Samson G, Tytgat GNJ. Cell proliferation kinetics in the gastric remnant. Eur J Cancer Clin Oncol 1985;21:73–9.
   PubMedGoogle Scholar
• Hong MK, Laskin WB, Herman BE, Johnston MH, Vargo JJ, Steinberg SM, et al. Expansion of the Ki-67 proliferative compartment correlates with degree of dysplasia in Barrett’s esophagus. Cancer 1995;75:423–9.
   PubMed Web of Science ®Google Scholar
• Herbst JJ, Berenson MM, McCloskey DW, Wiser WC. Cell proliferation in esophageal columnar epithelium (Barrett’s esophagus). Gastroenterology 1978;75:683–7.
   PubMedGoogle Scholar
• Polkowski W, van Lanschot JJB, ten Kate FJW, Baak JPA, Tytgat GNJ, Obertop H, et al. The value of p53 and Ki67 as markers for tumour progression in the Barrett’s dysplasia- carcinoma sequence. Surg Oncol 1995;4:163–71.
   PubMedGoogle Scholar
• Kim R, Clarke MR, Melhem MF, Young MA, Vanbibber MM, Safatle-Ribeiro AV, et al. Expression of p53, PCNA, and C- erbB-2 in Barrett’s metaplasia and adenocarcinoma. Dig Dis Sci 1997;42: 2453–62.
   Google Scholar
• Kataoka H, Joh T, Kasugai K, Kato T, Moriyama A. Mitogenic properties of human gastric juice. Dig Dis Sci 1997;42:1747–54.
   PubMedGoogle Scholar
• Lagergren J, Bergström R, Lindgren A, Nyrén O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999;340:825–31.
   PubMed Web of Science ®Google Scholar
• Vaezi MF, Richter JE. Synergism of acid and duodenogastro- esophageal reflux in complicated Barrett’s esophagus. Surgery 1995;117:699–704.
   PubMed Web of Science ®Google Scholar
• Caldwell MTP, Lawlor P, Byrne PJ, Walsh TN, Hennessy TPJ. Ambulatory oesophageal bile reflux monitoring in Barrett’s oesophagus. Br J Surg 1995;82:657–60.
   Google Scholar
• Lirón R, Parrilla P, Martinez de Haro LF, Ortiz A, Robles R, Luján JA, et al. Quantification of duodenogastric reflux in Barrett’s esophagus. Am J Gastroenterol 1997;92:32–6.
   Google Scholar
• Vaezi MF, Richter JE. Contribution of acid and duodenogas- trooesophageal reflux to oesophageal mucosal injury and symptoms in partial gastrectomy patients. Gut 1997;41:297–302.
   PubMed Web of Science ®Google Scholar
• Marshall REK, Anggiansah A, Manifold DK, Owen WA, Owen WJ. Effect of omeprazole 20 mg twice daily on duodenogastric and gastro-oesophageal bile reflux in Barrett’s oesophagus. Gut 1998;43: 603–6.
   Google Scholar
• Wilkinson SP, Biddlestone L, Gore S, Shepherd NA. Regression of columnar-lined (Barrett’s) oesophagus with omeprazole 40 mg daily: results of 5 years of continuous therapy. Aliment Pharmacol Ther 1999;13:1205–9.
   PubMed Web of Science ®Google Scholar
• Ouatu-Lascar R, Fitzgerald RC, Triadafilopoulos G. Differentiation and proliferation in Barrett’s esophagus and the effects of acid suppression. Gastroenterology 1999;117:327–35.
   Google Scholar
• van der Burgh A, Dees J, Hop WCJ, van Blankenstein M. Oesophageal cancer is an uncommon cause of death in patients with Barrett’s oesophagus. Gut 1996;39:5–8.
   PubMed Web of Science ®Google Scholar
• Peters JH, Clark GWB, Ireland AP, Chandrasoma P, Smyrk TC, DeMeester TR. Outcome of adenocarcinoma arising in Barrett’s esophagus in endoscopically surveyed and nonsurveyed patients. J Thorac Cardiovasc Surg 1994;108:813–22.
   PubMed Web of Science ®Google Scholar
• van Sandick JW, van Lanschot JJB, Kuiken BW, Tytgat GNJ, Offerhaus GJA, Obertop H. Impact of endoscopic biopsy surveillance of Barrett’s oesophagus on pathological stage and clinical outcome of Barrett’s carcinoma. Gut 1998;43:216–22.
   PubMed Web of Science ®Google Scholar
• Kapadia CR. Barrett’s esophagus: whom to screen? Still an unanswered question. Gastroenterology 1998;114:1101–2.
   Google Scholar